Your sweet snacks should still contribute meaningfully to your daily protein goals of 100-120g
Primary weight-loss endpoint: 28.7% mean reduction at 12 mg (avg 71.2 lbs lost) and 26.4% at 9 mg, vs
Thus, these results suggest that GLP-1RAs exhibit superior preventive effects on atherosclerotic CV events and can improve CV prognosis in T2D patients with a previous history of CV events (except ACS), and that such treatment effects could become apparent by, for example, comparing the results of CV outcomes trials with another class of incretin-based agents, namely dipeptidyl peptidase-4 (DPP-4) inhibitors [31,32,33]
In comparison, without insurance coverage Wegovy, Novo Nordisks semaglutide product that has been approved for weight loss, has a list price of approximate $1,350 per month